Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1036.2500 -8.60 (-0.82%)

NSE Sep 24, 2025 11:26 AM

Near 52W High of ₹1088.85

Volume: 125.3K

Zydus Lifesciences Ltd.

16 Sep 2022

1036.25

-0.82%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release dated September 16, 2022 titled 'Zydus receives tentative approval from the USFDA for Sugammadex Injection'

More from Zydus Lifesciences Ltd.

Recommended

Market trades lower, Swiggy approves Instamart sale to arm Scootsy Logistics

Trendlyne Marketwatch | 24 Sep 2025, 11:21AM

Five stocks to buy from analysts this week - September 23, 2025

The Baseline | 23 Sep 2025, 06:11PM

Earnings Call Transcript - Cadila Healthcare